2023
DOI: 10.7150/ijbs.82317
|View full text |Cite
|
Sign up to set email alerts
|

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

Abstract: Cancer is a multi-step disease caused by the accumulation of genetic mutations and/or epigenetic changes, and is the biggest challenge around the world. Cytokines, including chemokines, exhibit expression changes and disorders in all human cancers. These cytokine abnormalities can disrupt homeostasis and immune function, and make outstanding contributions to various stages of cancer development such as invasion, metastasis, and angiogenesis. Chemokines are a superfamily of small molecule chemoattractive cytoki… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(8 citation statements)
references
References 184 publications
0
8
0
Order By: Relevance
“…Most of the GPCRs included in the risk score model used in this study are either FDA-approved drug targets or drug targets in the phase of clinical trials. Small molecule inhibitors of ACKR3 were manufactured, including CCX771, CCX754 and CCX733 [ 63 ], among which the former two had already shown the capability of reducing nearly half of colorectal carcinoma lung metastases in vivo [ 64 ]. Maraviroc, including CCR5 and CCR3 antagonists, has been approved for the treatment of human immunodeficiency virus (HIV) infection [ 65 ].…”
Section: Discussionmentioning
confidence: 99%
“…Most of the GPCRs included in the risk score model used in this study are either FDA-approved drug targets or drug targets in the phase of clinical trials. Small molecule inhibitors of ACKR3 were manufactured, including CCX771, CCX754 and CCX733 [ 63 ], among which the former two had already shown the capability of reducing nearly half of colorectal carcinoma lung metastases in vivo [ 64 ]. Maraviroc, including CCR5 and CCR3 antagonists, has been approved for the treatment of human immunodeficiency virus (HIV) infection [ 65 ].…”
Section: Discussionmentioning
confidence: 99%
“…CXCL12/CXCR4 axis also plays an important role in the progression of coronary artery disease. CXCR4 positive endothelial progenitor cells promote angiogenesis through CXCL12 signaling and reduce coronary artery stenosis and poor blood flow [13] .…”
Section: Discussionmentioning
confidence: 99%
“…CXCL-12 is important for MM cell evasion of apoptosis and survival by upregulating survivin, B-cell lymphoma (BCL)-2, and ATP-binding cassette (ABCC)-1, a multidrug resistance transporter [154]. Further, CXCL-12 promotes homing of CXCR-4-expressing MM cells to CXCL-12+ stromal niches in the BM and retention through strong adhesion of α4β1 integrin on MMPCs to VCAM-1 in the BM microvasculature [114,155].…”
Section: Cxcl-12-abundant Reticular (Cxar) Cellsmentioning
confidence: 99%